Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome Inhibitors-Reference-Cited by-同舟云学术

Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome Inhibitors

Published:2022-06-21 Issue:13 Volume:65 Page:9350-9375
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Zhang Hao¹^ORCID,Ginn John²,Zhan Wenhu¹^ORCID,Liu Yi J.¹,Leung Annie³,Toita Akinori²,Okamoto Rei²,Wong Tzu-Tshin²,Imaeda Toshihiro²,Hara Ryoma²,Yukawa Takafumi²,Michino Mayako²,Vendome Jeremie⁴,Beuming Thijs⁴,Sato Kenjiro²,Aso Kazuyoshi²,Meinke Peter T.²^ORCID,Nathan Carl F.¹,Kirkman Laura A.¹³,Lin Gang¹^ORCID

Affiliation:

1. Department of Microbiology & Immunology, Weill Cornell Medicine, 1300 York Ave., New York, New York 10065, United States

2. Tri-Institutional Therapeutics Discovery Institute, 413 E. 69th St, New York, New York 10065, United States

3. Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, 1300 York Ave., New York, New York 10065, United States

4. Schrödinger, Inc., New York, New York 10036, United States

Funder

Weill Cornell Medical College

Brockman Foundation

National Institute of Allergy and Infectious Diseases

Cornell University

Publisher

American Chemical Society (ACS)